These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354 [TBL] [Abstract][Full Text] [Related]
3. Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Marvin JE; Trubin PA; Azar MM Transpl Infect Dis; 2024 Aug; 26(4):e14329. PubMed ID: 38971997 [No Abstract] [Full Text] [Related]
4. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes. Jorgenson MR; Descourouez JL; Cardinale B; Lyu B; Astor BC; Garg N; Saddler CM; Smith JA; Mandelbrot DA Transpl Infect Dis; 2019 Jun; 21(3):e13080. PubMed ID: 30891915 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression. Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971 [TBL] [Abstract][Full Text] [Related]
6. Treatment of cytomegalovirus infection after renal transplantation: experience from a single center in China. Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Xiang HL; Hou J; Tian XH; Zheng J; Ding CG; Fan P; Liu HB Ann Transplant; 2013 Mar; 18():125-35. PubMed ID: 23792512 [TBL] [Abstract][Full Text] [Related]
7. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790 [TBL] [Abstract][Full Text] [Related]
8. Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance. van der Beek MT; Berger SP; Vossen AC; van der Blij-de Brouwer CS; Press RR; de Fijter JW; Claas EC; Kroes AC Transplantation; 2010 Feb; 89(3):320-6. PubMed ID: 20145523 [TBL] [Abstract][Full Text] [Related]
9. Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature. Hodowanec AC; Simon DM Transpl Infect Dis; 2012 Oct; 14(5):E116-20. PubMed ID: 22938143 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L; Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546 [TBL] [Abstract][Full Text] [Related]
11. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Limaye AP; Corey L; Koelle DM; Davis CL; Boeckh M Lancet; 2000 Aug; 356(9230):645-9. PubMed ID: 10968438 [TBL] [Abstract][Full Text] [Related]
12. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene. Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus polyradiculopathy of late onset in a young renal transplant recipient. Papasotiriou M; Papachristou E; Marangos M; Koukoulaki M; Savvidaki E; Kalliakmani P; Goumenos DS Clin Nephrol; 2013 Jul; 80(1):75-8. PubMed ID: 23803598 [TBL] [Abstract][Full Text] [Related]
15. Panresistant cytomegalovirus in a kidney transplant recipient. Yost SE; Echeverria A; Jie T; Kaplan B Pharmacotherapy; 2014 Jan; 34(1):e1-3. PubMed ID: 24277702 [TBL] [Abstract][Full Text] [Related]
16. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation. West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740 [TBL] [Abstract][Full Text] [Related]
17. Current characteristics and outcome of cytomegalovirus infections after kidney transplantation. Helanterä I; Schachtner T; Hinrichs C; Salmela K; Kyllönen L; Koskinen P; Lautenschlager I; Reinke P Transpl Infect Dis; 2014 Aug; 16(4):568-77. PubMed ID: 24966022 [TBL] [Abstract][Full Text] [Related]